A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

In Canada, ED overcrowding, particularly with older adults, is a healthcare system failure that must be addressed across ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

An imaging-derived muscle-fat index predicts heart failure, cardiovascular deaths, and all-cause deaths more accurately than BMI and waist-based measures.

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart ...

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...

Roflumilast 0.05% (Zoryve), a topical phosphodiesterase-4 inhibitor, is currently approved for treating mild-to-moderate AD in children aged 2 years or older; it was approved for ...

The EMA has alerted healthcare professionals to a small increased risk for meningioma with the progestogen-based contraceptives desogestrel and etonogestrel.

AI-based computer-aided detection devices during colonoscopy was associated with higher adenoma detection rates than usual ...